3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Mastocytosis
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hepatoblastoma
1
Dupuytren Contracture
1
Congenital Abnormalities
1
Anemia, Refractory
1
Interventions
Cyclophosphamide
17
venetoclax
11
fludarabine
10
Cytarabine
10
Mycophenolic Acid
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Tacrolimus
5
Methotrexate
5
Daunorubicin
5
Cyclosporine
5
Azacitidine
5
ruxolitinib
4
ponatinib
4
blinatumomab
4
Vincristine
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Dexamethasone
4
asciminib
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
revumenib
2
quizartinib
2
pegaspargase
2
nilotinib
2
ibrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Transplantation
×
90 days
×
Clear all
No trials found.